Literature DB >> 33275827

Application of new international classification of adult-onset diabetes in Chinese inpatients with diabetes mellitus.

Weihao Wang1, Xiaobei Pei1, Lina Zhang1, Zhi Chen2, Dong Lin1, Xiaoye Duan1, Jingwen Fan1, Qi Pan1, Lixin Guo1.   

Abstract

BACKGROUND: To determine whether the new international cluster-based classification method can be applied to Chinese inpatients with diabetes mellitus (DM).
METHODS: Adult patients with DM hospitalized in our tertiary care centre from January 2017 to December 2018 were included in the study. K-means cluster analysis was done in clusters based on glutamic acid decarboxylase antibodies, body mass index, glycosylated haemoglobin, homeostasis model-assessed beta cell function, insulin resistance index, and age at diagnosis of DM. Chi-square test was used to analyse inter-subgroup differences in DM-related complications and family history of DM. p < 0.05 was considered significant.
RESULTS: A total of 1152 inpatients with DM were included in the study. Five subgroups were obtained by cluster analysis with highest proportion of population in mild obesity-related DM subgroup (34.55%), followed by mild age-related DM (21.55%), severe insulin deficiency DM (20.51%), severe insulin resistance DM (19.02%), and severe autoimmune DM subgroup (4.36%). The prevalence of diabetic retinopathy, diabetic peripheral vascular disease, diabetic ketosis, coronary heart disease, hypertension, and family history of DM differed significantly among the subgroups (p < 0.05 for all).
CONCLUSIONS: This cluster-based classification could be applied to hospitalized adult patients with DM in China. It might help in strategizing for DM patients, and hence, improve management of DM in these patients.
© 2020 John Wiley & Sons Ltd.

Entities:  

Keywords:  classification; cluster analysis; diabetes; inpatients

Mesh:

Substances:

Year:  2020        PMID: 33275827     DOI: 10.1002/dmrr.3427

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  10 in total

1.  Novel clusters of newly-diagnosed type 2 diabetes and their association with diabetic retinopathy: a 3-year follow-up study.

Authors:  Yu Liu; Miaomiao Sang; Yang Yuan; Ziwei Du; Wei Li; Hao Hu; Liang Wen; Fenghua Wang; Haijian Guo; Bei Wang; Duolao Wang; Zilin Sun; Shanhu Qiu
Journal:  Acta Diabetol       Date:  2022-03-21       Impact factor: 4.280

Review 2.  Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations.

Authors:  Calvin Ke; K M Venkat Narayan; Juliana C N Chan; Prabhat Jha; Baiju R Shah
Journal:  Nat Rev Endocrinol       Date:  2022-05-04       Impact factor: 47.564

3.  New clusters of serum electrolytes aid in stratification of diabetes and metabolic risk.

Authors:  Yanan Hou; Jiali Xiang; Huajie Dai; Tiange Wang; Mian Li; Hong Lin; Shuangyuan Wang; Yu Xu; Jieli Lu; Yuhong Chen; Weiqing Wang; Guang Ning; Zhiyun Zhao; Yufang Bi; Min Xu
Journal:  J Diabetes       Date:  2021-12-28       Impact factor: 4.530

4.  Glycemic control of children and adolescents with type 1 diabetes improved after COVID-19 lockdown in Italy.

Authors:  Marco Marigliano; Claudio Maffeis
Journal:  Acta Diabetol       Date:  2021-02-02       Impact factor: 4.280

5.  Sodium-glucose co-transporter 2 inhibitors in COVID-19: meeting at the crossroads between heart, diabetes and infectious diseases.

Authors:  Theocharis Koufakis; Antonis N Pavlidis; Symeon Metallidis; Kalliopi Kotsa
Journal:  Int J Clin Pharm       Date:  2021-03-09

6.  Novel Subgroups and Chronic Complications of Diabetes in Middle-Aged and Elderly Chinese:A Prospective Cohort Study.

Authors:  Fei Wang; Ruizhi Zheng; Ling Li; Min Xu; Jieli Lu; Zhiyun Zhao; Mian Li; Tiange Wang; Shuangyuan Wang; Yufang Bi; Yu Xu; Guang Ning; Weimin Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-26       Impact factor: 5.555

7.  Clinical Characteristics of Inpatients With New-Onset Diabetes Mellitus in Eastern China: Based on Novel Clustering Analysis.

Authors:  Xueke Song; Yingqi Lv; Nan Huang; Jinfang Sun; Ting Yang; Xiaoyuan Wang; Jianan Zhang; Ziwei Zhou; Huihua Gao; Jie Li; Wei Zhang; Han Yin; Qiong Wei; Kun Wang; Ling Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-27       Impact factor: 6.055

8.  The relationship between diabetes and clinical outcomes in COVID-19: a single-center retrospective analysis.

Authors:  Tamaryn Fox; Kathleen Ruddiman; Kevin Bryan Lo; Eric Peterson; Robert DeJoy; Grace Salacup; Jerald Pelayo; Ruchika Bhargav; Fahad Gul; Jeri Albano; Zurab Azmaiparashvili; Catherine Anastasopoulou; Gabriel Patarroyo-Aponte
Journal:  Acta Diabetol       Date:  2020-08-17       Impact factor: 4.280

9.  Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy.

Authors:  S Ciardullo; F Zerbini; S Perra; E Muraca; R Cannistraci; M Lauriola; P Grosso; G Lattuada; G Ippoliti; A Mortara; G Manzoni; G Perseghin
Journal:  J Endocrinol Invest       Date:  2020-08-10       Impact factor: 4.256

10.  Risk factors for Covid-19 severity and fatality: a structured literature review.

Authors:  Dominik Wolff; Sarah Nee; Natalie Sandy Hickey; Michael Marschollek
Journal:  Infection       Date:  2020-08-28       Impact factor: 7.455

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.